CNTX · Context Therapeutics Inc. · Documents
$0.24
+0.00 (+1.57%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$21.99M
Shares
91.88M
Volume · Oct 23
1.49M
Avg daily vol (3M)
1.55M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-08-05 | — | |
| 10-Q | — | 2026-08-05 | 2026-06-30 | |
| 8-K | — | 2026-07-31 | 2026-07-29 | |
| 8-K | — | 2026-06-26 | 2026-06-24 | |
| 8-K | — | 2026-06-15 | — | |
| Investor Event Transcript | — | 2026-06-03 | 2026-06-30 | |
| 8-K | — | 2026-05-18 | 2026-05-14 | |
| 10-Q | — | 2026-05-06 | 2026-03-31 | |
| 8-K | — | 2026-05-01 | 2026-04-30 | |
| DEF 14A | — | 2026-04-28 | — | |
| ARS | — | 2026-04-28 | 2025-12-31 | |
| DEFA14A | — | 2026-04-28 | — | |
| PRE 14A | — | 2026-04-17 | 2026-06-24 | |
| 8-K | — | 2026-04-02 | — | |
| 10-K | — | 2026-03-23 | 2025-12-31 | |
| 8-K | — | 2026-03-23 | — | |
| 8-K | — | 2026-03-13 | 2026-03-11 | |
| 8-K | — | 2026-02-27 | 2026-02-24 | |
| 8-K | — | 2026-01-08 | — | |
| 8-K | — | 2025-11-05 | — | |
| 10-Q | — | 2025-11-05 | 2025-09-30 | |
| 8-K | — | 2025-10-24 | — | |
| 8-K | — | 2025-10-20 | 2025-10-17 | |
| 8-K | — | 2025-09-02 | 2025-08-28 | |
| 10-Q | — | 2025-08-06 | 2025-06-30 | |
| 8-K | — | 2025-06-12 | — | |
| 8-K | — | 2025-06-02 | — | |
| 10-Q | — | 2025-05-07 | 2025-03-31 | |
| ARS | — | 2025-04-15 | 2024-12-31 | |
| DEF 14A | — | 2025-04-15 | 2025-06-12 | |
| DEFA14A | — | 2025-04-15 | — | |
| 8-K | — | 2025-04-09 | — | |
| PRE 14A | — | 2025-04-04 | 2025-06-12 | |
| 10-K | — | 2025-03-20 | 2024-12-31 | |
| 8-K | — | 2025-02-28 | 2025-02-27 | |
| 8-K | — | 2025-01-14 | — | |
| 8-K | — | 2025-01-13 | 2025-01-10 | |
| 8-K | — | 2024-12-23 | — | |
| 8-K | — | 2024-12-02 | — | |
| S-3 | — | 2024-11-06 | — | |
| 10-Q | — | 2024-11-06 | 2024-09-30 | |
| 8-K | — | 2024-09-23 | — | |
| 8-K | — | 2024-09-17 | — | |
| 8-K | — | 2024-09-04 | — | |
| 10-Q | — | 2024-08-07 | 2024-06-30 | |
| DEF 14A | — | 2024-07-24 | 2024-09-17 | |
| DEFA14A | — | 2024-07-24 | — | |
| PRE 14A | — | 2024-07-12 | 2024-09-17 | |
| 8-K | — | 2024-07-10 | 2024-07-09 | |
| 8-K | — | 2024-06-14 | 2024-06-13 |
Showing 1–50 of 105 filings
Key facts
CIK
1842952
CUSIP
21077P108
13F (30d)
11 filings
11 filers
Visit website
Investor relations